5th Stanford Drug Discovery Symposium (SDDS 2021) to be Held Virtually This Year on April 19-20, 2021
There is free registration for all interested attendees: http://tinyurl.com/SDDS2021. Co-Sponsored by the Stanford Cardiovascular Institute, Stanford Cancer Institute, Stanford Cardiovascular Health, and many others.
STANFORD, Calif., March 23, 2021 (Newswire.com) - Featuring talks from drug discovery leaders, the Stanford Drug Discovery Symposium, April 19-20, 2021, is a free, virtual symposium hosted by Stanford University.
This event offers an exciting opportunity for the public to hear about how drug research and development is done in the U.S. and globally. Esteemed guests are from major pharmaceutical companies, federal policymakers, venture capitalists, start-up companies, and scientists making groundbreaking advances. This year also offers a look into how COVID-19 has led to change in these spaces. Register for free at http://tinyurl.com/SDDS2021.
This year's SDDS "Lifetime Achievement Award" will be awarded to Doug Lowy, MD, Principal Deputy Director, National Cancer Institute, and John Schiller, Ph.D., Deputy Chief, Laboratory of Cellular Oncology, for their work on the HPV vaccine.
A selection of guest speakers and participants include:
- Andrew Plump, MD, Ph.D., President, Research & Development of Takeda Pharmaceutical Company Limited
- Young Sohn, Chairman of the Board, HARMAN, and Senior Advisor, Samsung Electronics
- Marcus Schindler, Ph.D., Executive Vice President and CSO of Research & Early Development, Novo Nordisk
- Hal Barron, MD, CSO and President, GlaxoSmithKline
- Wendy Young, Ph.D., Senior Vice President, Small Molecule Drug Discovery, Genentech
- Nanna Lünebourg, Ph.D., MBA, Partner, Novo Ventures
- Taiyin Yang, Ph.D., Executive Vice President, Pharmaceutical Development and Manufacturing, Gilead
- Janet Woodcock, MD, Acting Commissioner, FDA
- Kathrin Jansen, Ph.D., Senior Vice President, Head of Vaccine Research and Development, Pfizer
- Mir Imran, MS, Chairman and CEO, Rani Therapeutics
- Ken Mills, President and CEO, REGENXBIO
- George Yancopoulos, MD, Ph.D., President and CSO, Regeneron
- Joan Mannick, MD, Head of Research and Development, Life Biosciences
- Mathai Mammen, MD, Ph.D., Global Head of Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
- Levi Garraway, MD, Ph.D., CMO, Genentech
- Helene Gayle, MD, MPH, President and CEO, The Chicago Community Trust
- Mark Smith, MD, MBA, Founding President and CEO, California Healthcare Foundation
- Elias Zerhouni, MD, Former President for R&D, Sanofi; former Director of the NIH; former U.S. Presidential Science Envoy
- Robert Califf, MD, Head of Strategy and Policy, Verily Life Sciences and Google Health Divisions of Alphabet
A complete list of speakers and registration information can be found at http://tinyurl.com/SDDS2021.
SDDS 2021 is sponsored in part by Alexandria Ventures, Cytokinetics, Khloris Biosciences, Merck, OptinaDX, REGENXBIO Inc., Stanford Cancer Institute, Stanford Cardiovascular Institute, Santen, Novo Nordisk, Stanford Cardiovascular Health, Vala Sciences, Codex DNA, Servier BioInnovation, and 10X Genomics.
Media Sponsors include Biocom California, Keystone Symposia, and California Life Sciences.
To sponsor, or for other information, press contact: [email protected].
Source: Stanford Cardiovascular Institute
Share:
Tags: biotech, biotechnology, Drug, Drug Discovery, free, pharmaceutical, SDDS, Stanford, Stanford Drug Discovery, Stanford Drug Discovery Symposium, Stanford University
